GlassScriptPhysician profile
Sonia Parker
NPI 1083035562
$8,462.86
in general payments reported to CMS, 2019-2025
32 companies · $2,286 in 2025
The $2,286 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $479 · 2022: $1,354 · 2023: $1,902 · 2024: $2,442 · 2025: $2,286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,613 · Education: $15.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,613.48 |
| Education | $15.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,417.40 | 2021-2025 | Repatha, Repatha, Evenity |
| Novo Nordisk INC | $828.94 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $809.91 | 2021-2025 | Breztri, Airsupra, Lokelma |
| Novartis Pharmaceuticals Corporation | $614.08 | 2022-2025 | |
| Lilly USA, LLC | $475.43 | 2022-2025 | Mounjaro, Zepbound |
| Esperion Therapeutics, INC. | $444.47 | 2021-2025 | Nexletol, Nexlizet |
| Boston Scientific Corporation | $438.97 | 2022-2024 | Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $383.38 | 2022-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $357.02 | 2022-2025 | Verquvo, Winrevair |
| Abbvie INC. | $344.96 | 2023-2025 | |
| Alnylam Pharmaceuticals INC. | $267.23 | 2022-2024 | Amvuttra, Onpattro |
| E.R. Squibb & Sons, L.L.C. | $240.18 | 2021-2024 | Eliquis, Zeposia |
| Medtronic, INC. | $145.02 | 2024 | Linq II |
| Regeneron Healthcare Solutions, INC. | $124.99 | 2025 | Dupixent |
| Teva Pharmaceuticals USA, INC. | $124.99 | 2024 | Austedo Xr |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $124.56 | 2024 | Voquezna |
| Glaxosmithkline, LLC. | $123.41 | 2025 | Arexvy |
| Madrigal Pharmaceuticals | $122.84 | 2025 | Rezdiffra |
| Biohaven Pharmaceutical Holding Company LTD. | $121.09 | 2022 | |
| Ascensia Diabetes Care US INC. | $110.73 | 2025 | |
| Atricure, INC. | $106.80 | 2022 | |
| Inspire Medical Systems, INC. | $106.64 | 2023 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $103.02 | 2022-2025 | |
| Ardelyx, INC. | $101.03 | 2023 | Ibsrela |
| Pfizer INC. | $87.25 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $76.93 | 2023 | Opsumit, Uptravi |
| Eisai INC. | $61.24 | 2021 | |
| Irhythm Technologies, INC. | $59.97 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Abiomed | $51.75 | 2025 | |
| Amarin Pharma, INC. | $36.52 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $36.12 | 2022-2023 | Xarelto |
| Kiniksa Pharmaceuticals, LTD. | $15.99 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonia Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.